Last reviewed · How we verify
GRT-R914, samRNA-Spikebeta-TCE9 — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
GRT-R914, samRNA-Spikebeta-TCE9 (GRT-R914, samRNA-Spikebeta-TCE9) — Gritstone bio, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| GRT-R914, samRNA-Spikebeta-TCE9 TARGET | GRT-R914, samRNA-Spikebeta-TCE9 | Gritstone bio, Inc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- GRT-R914, samRNA-Spikebeta-TCE9 CI watch — RSS
- GRT-R914, samRNA-Spikebeta-TCE9 CI watch — Atom
- GRT-R914, samRNA-Spikebeta-TCE9 CI watch — JSON
- GRT-R914, samRNA-Spikebeta-TCE9 alone — RSS
Cite this brief
Drug Landscape (2026). GRT-R914, samRNA-Spikebeta-TCE9 — Competitive Intelligence Brief. https://druglandscape.com/ci/grt-r914-samrna-spikebeta-tce9. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab